Autoimmune connective tissue disease Flashcards

1
Q

What antibodies are associated with polymyositis and dermatomyositis?

A
  • Anti Jo-1
  • Anti Mi-2
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

What antibody is associated with systemic sclerosis?

A

Anti-Scl70

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Describe Polymyositis and dermatomyositis?

A
  • Proximal skeletal and smooth muscle inflammation
    • Autoimmune-mediated
  • Myalgia -> dysphagia, dysphonia, respiratory weakness
  • Skin involvement in dermatomyositis
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Clinical features of PM and DM?

A
  • Symmetrical proximal muscle weakness / pain
    • Affect LLs more than ULs
  • Difficulty rising from chair, climbing stairs and lifting
  • Fever, weight loss, fatigue
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

What should always be done in polymyositis and dermatomyositis?

A

Screen for cancer

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Describe Dermatomyositis?

A
  • Myositis plus skin signs:
    • Rash over back and shoulders
      • Discolouration of the eyelid +/- periorbital oedema
    • Nail-fold capillary dilation
    • Gottron’s papules (rough red papules over knuckles)
    • Raynauds
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

What are the extra-muscular signs in both polymyositis and dermatomyositis?

A
  • Fever
  • Arthralgia
  • Raynaud’s
  • Interstitial lung fibrosis
  • Myocardial involvement
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Describe the tests for polymyositis and dermatomyositis?

A
  • Creatine kinase can be raised
  • Muscle biopsy (use MRI to identify abnormal muscle for biopsy)
    • Confirms diagnosis: Fibre necrosis and inflammatory infiltrate
  • Autoantibody associations
    • Anti-Mi2, Anti-Jo1
  • Electromyography (EMG)
    • Can identify non-AI/inflammatory myopathies
  • Screen for malignancy
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Namr some differentials for polymyositis and dermatomyositis?

A
  • Drugs
  • Infection (HIV)
  • Rhabdomyolysis
  • Muscular dystrophy
  • Inclusion-body myositis
  • Carcinomatous myopathy
  • Endocrine/metabolic myopathy
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

What drugs can cause polymyositis and dermatomyositis?

A
  • Statins
  • Colchicine
  • Chloroquine
  • Penicillamine
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Describe the mangagement of polymyositis and dermatomyositis?

A
  • Prednisolone PO
  • Methylprednisolone IV
    • If respirsatory/pharyngeal weakness
  • Resistant cases:
    • Methotrexate + mycophenolate
  • Skin predominant disease
    • Hydroxychloroquine
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Describe systemic sclerosis?

A
  • AI disorder of connective tissue causing:
    • Fibrosis of skin, organs and vasculature
  • Autoantibodies:
    • ANA, anti-centromere
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Clinical features of Systemic sclerosis?

A
  • Skin
    • Non-pitting oedema of fingers, shiny, taut skin
  • Raynaud’s phenomenon
  • Arthralgia, tenosynovitis, muscle weakness
  • Dysphagia, odynophagia
  • Pulmonary hypertension
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

What is scleroderma?

A
  • Systemic sclerosis without internal organ invovlement
  • Tightening and fibrosis of skin
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Describe Limited cutaneous systemic sclerosis?

A
  • Raynauds
  • Scleroderma of face and distal limbs
  • Anti-centromere antibodies
  • A subtype of limited systemic sclerosis is CREST syndrome
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Treatment for limited systemic sclerosis?

A
  • Sildenafil
  • Bosentan
17
Q

Describe diffuse skin involvement of systemic sclerosis?

A
  • Can involve the whole body
  • Anti-Scl70 anitbodies in 70%
  • Anti-RNA polymerase in 20%
  • Monitor BP and perform regular echos and spirometry
18
Q

What are the indicators of a poor prognosis in systemic sclerosis?

A
  • Older age
  • High ESR
  • Proteinuria
  • Pumonary HTN
  • Diffuse disease
19
Q

Describe the management of systemic sclerosis?

A
  • No cure
  • Raynaud’s
    • Avoid cold, thick socks/gloves, sildenafil
  • Interstitial lung disease
    • Glucocorticoids + cyclophosphamide
  • Hypertension
    • Regular ACE-i/ARBs
  • Pulmonary HTN
    • Bosentan, heart-lung transplant
20
Q

Describe Primary Sjogren’s syndrome?

A
  • Lymphocytic infiltration of salivary and lacrimal glands
    • => Glandular fibrosis and exocrine failure
21
Q

Risk factors for Primary Sjogren’s syndrome?

A
  • 40-60 years
  • Female
  • HLA-B8/ HLA-DR3
22
Q

Clinical features of Primary Sjogren’s syndrome?

A
  • Keratoconjunctivitis
  • Non-erosive arthralgia
  • Enlarged salivary glands
  • Raynaud’s phenomenon
23
Q

Autoantibodies detected in Primary Sjogren’s syndrome?

A
  • Rheumatoid factor
  • Antinuclear antibody (ANA)
  • Anti-Ro, Anti-La
  • Thyroid autoantibody
24
Q

Describe the diagnosis of Primary sjogren’s syndrome?

A
  • Schirmer tear test
    • Normal is >6mm of wetting
  • Elevated ESR and hypogammaglobulinaemia
  • Positive autoantibody
25
Management of Primary sjogren's syndrome?
* No disease modifying treatment * Tear substitiutes * Lubrication for vaginal dryness * Hydroxychloroquine for skin and MSK features
26
Read the presentation of Sjogrens syndrome
27
Read the presentation of systemic sclerosis
28
Presentation of idiopathic inflammatory myopathies? Polymyositis, dermatomyositis
29
Read the case presentation of SLE
30
Investigations into dermatomyositis?
* ANA positive * Anti-Mi-2 * Anti-Jo-1 * SRP antibodies
31
Describe CREST syndrome?
* Subtype of limited cutaneous systemic sclerosis * Calcinosis * Raynauds * oEsophageal dysmotility * Sclerodactyly * Telangiectasia
32